INFORMATION ABOUT COVID-19 (Coronavirus)
FCS, in partnership with the Community Oncology Alliance (COA) and oncology care providers across the country, is urging state governors to provide us with priority approval and sufficient vaccine supply to administer to our patients with cancer and blood disorders. Read the full letter here.
A MESSAGE TO OUR PATIENTS AND THE COMMUNITIES WE SERVE
Despite the many ongoing challenges of the COVID-19 pandemic, cancer care cannot wait. Florida Cancer Specialists & Research Institute (FCS) remains open and fully dedicated to safely and responsibly serving our communities with exceptional care, close to home.
Building upon our strong foundation and a shared spirit of innovation, our FCS team members continue to enact stringent procedures and safeguards to address our three highest priorities: keeping patients safe, keeping physicians and employees safe, and providing uninterrupted care and service.
It is our privilege and our passion to serve our patients and our community, and we are proud to update you about our efforts. We invite you to read our complete message here: https://flcancer.com/en/COVID-19-letter/
Throughout this unprecedented pandemic, we've been deeply touched by the thoughtful gestures and acts of kindness received from our patients and community neighbors. We’ve been equally impressed with the positivity of our dedicated team members. Please enjoy this gallery spotlighting these special moments. We are in this together, every step of the way.
During hurricane season, we will continue to update office closures, changes in hours or any other pertinent information.
For closures and more information:
In the News
Happy Holidays from Florida Cancer Specialists
As a leader in medical oncology and hematology, we’re at the forefront of science and research to provide our patients with the best treatment possible close to home. We all need hope, and our expertise will help improve the quality of life for all patients during their journey.
The only community oncology practice in Florida with this designation, we provide a full range of cancer services with a demonstrated focus on delivering quality and value through patient-centered, coordinated care.
In the past 4 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.
We are a strategic site of the Sarah Cannon Research Institute — one of the world’s leading clinical research organizations.
We have 35 Florida locations directly participating in late-phase clinical trials with early phase research being conducted within our Sarasota-based Drug Development Unit.
Recognized by the American Society of Clinical Oncology (ASCO®) with a national Clinical Trials Participation Award, we offer patients access to more clinical trials than any private oncology practice in the state of Florida.
Florida Cancer Specialists is an accredited member of the American College of Radiology.
Florida Cancer Specialists is participating in the Oncology Care Model (OCM), a new initiative by Medicare to deliver high quality, more coordinated care to cancer patients undergoing chemotherapy.